Journal of International Reproductive Health/Family Planning ›› 2023, Vol. 42 ›› Issue (6): 513-518.doi: 10.12280/gjszjk.20230263

• Review • Previous Articles     Next Articles

Research Progress of Focal Segmental Glomerulosclerosis and Neurodevelopmental Syndrome Caused by the Mutation of TRIM8 Gene

DENG Quan-feng, XIN Min, XIA Lai-shuo, WANG Yi-fan, LIU Jin-xiu()   

  1. Prenatal Diagnosis Center Laboratory, Hefei Binhu Hospital, Hefei 230000, China (DENG Quan-feng); Jinan Yinfeng Medical Laboratory, Jinan 250000, China (XIN Min, XIA Lai-shuo, WANG Yi-fan, LIU Jin-xiu)
  • Received:2023-06-30 Published:2023-11-15 Online:2023-11-09
  • Contact: LIU Jin-xiu E-mail:liujinxiu1987@163.com

Abstract:

Focal segmental glomerulosclerosis and neurodevelopmental syndrome (FSGSNEDS) is a rare autosomal dominant disease caused by the mutation of TRIM8 gene encoding tripartite motif protein 8 on chromosome 10q24.32, which is characterized by developmental delay, renal diseases and epilepsy. FSGSNEDS often progresses to end-stage renal disease after the illness sets in. The phenotype of patients varies greatly, while there are few related studies. A total of 24 cases have been described until September 15, 2023. The definite diagnosis mainly depends on gene testing. At present, there is no specific therapy for FSGSNEDS, and the treatment methods are mainly targeted in the supportive care. Patients usually presented pharmaco-resistant epilepsy, and renal abnormalities were resistant to steroid therapy, whereas optimistic prognosis was expected undergoing early renal transplantation. This article reviews the advances in FSGSNEDS, in order to further improve the understanding of this disease.

Key words: Glomerulosclerosis, focal segmental, Neurodevelopmental disorders, TRIM8 gene, Epilepsy, Kidney system diseases, Diagnosis, Therapy